
Martlet Capital
Description
Martlet Capital is a prominent early-stage investor based in Cambridge, United Kingdom, specializing in providing patient capital to deep tech and life science startups. The firm primarily targets companies with high growth potential that are either located in or have strong ties to the vibrant Cambridge ecosystem. Their investment philosophy emphasizes long-term support, aiming to nurture innovative ventures from their nascent stages through significant growth phases.
As a seed-stage investor, Martlet Capital typically deploys initial cheques ranging from approximately $63,000 to $630,000. These investments are frequently made alongside other co-investors, demonstrating a collaborative approach to funding rounds. Since its inception in 2011, Martlet Capital has built a substantial portfolio, having made over 70 investments in promising startups across its target sectors. This extensive track record underscores their active role in the regional startup landscape.
Beyond capital, Martlet Capital provides significant value to its portfolio companies through access to a robust network of experienced entrepreneurs and advisors. Their deep understanding of the Cambridge innovation ecosystem further enhances their ability to support founders. The success of their portfolio is evident in the impressive follow-on funding secured by their companies, which collectively have raised over $315 million. This substantial sum highlights the quality of Martlet's initial investments and their ability to attract further capital into their ventures. The firm's commitment to fostering groundbreaking technologies and scientific advancements solidifies its position as a key player in the UK's deep tech and life science investment scene.
Investor Profile
Martlet Capital has backed more than 49 startups, with 1 new investments in the last 12 months alone. The firm has led 6 rounds, about 12% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Pre Seed rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States.
- Strong thematic focus on Biotechnology, Health Care, Software.
- Typical check size: $63K – $630K.
Stage Focus
- Seed (57%)
- Series A (20%)
- Pre Seed (8%)
- Angel (6%)
- Series B (6%)
- Series Unknown (2%)
Country Focus
- United Kingdom (96%)
- United States (4%)
Industry Focus
- Biotechnology
- Health Care
- Software
- Information Technology
- Pharmaceutical
- Artificial Intelligence (Ai)
- Medical
- Network Security
- Quantum Computing
- Telecommunications
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.